PELL Bio-Med Technology Co (TPE:6949) FCF Yield %: -0.91 (As of Jun. 30, 2026)


TPE:6949 PELL Bio-Med Technology Co Ltd TPE:6949
13 GF Score
Price NT$856.00
! 5 Warning Signs
View Full Analysis

What is PELL Bio-Med Technology Co FCF Yield %?

PELL Bio-Med Technology Co TPE:6949 -0.70% 13 FCF Yield % is -0.91 as of Jun. 30, 2026. GuruFocus rates TPE:6949 with a GF Score™ of 13/100. The stock has 5 warning signs investors should review. Among 1,415 Biotechnology companies, PELL Bio-Med Technology Co ranks better than 79.51% on this metric.

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, PELL Bio-Med Technology Co's Trailing 12-Month Free Cash Flow is NT$-508.89 Mil, and Market Cap is NT$56,102.28 Mil. Therefore, PELL Bio-Med Technology Co's FCF Yield % for today is -0.91%.

The historical rank and industry rank for PELL Bio-Med Technology Co's FCF Yield % or its related term are showing as below:

TPE:6949' s FCF Yield % Range Over the Past 10 Years
Min: -11.67   Med: -3.06   Max: -0.9
Current: -0.91

During the past 5 years, the highest FCF Yield % of PELL Bio-Med Technology Co was -0.90%. The lowest was -11.67%. And the median was -3.06%.

TPE:6949's FCF Yield % is ranked better than
79.51% of 1415 companies
in the Biotechnology industry
Industry Median: -9.62 vs TPE:6949: -0.91

PELL Bio-Med Technology Co's FCF Margin % for the quarter that ended in Dec. 2025 was -2,555.36%.

PELL Bio-Med Technology Co FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

PELL Bio-Med Technology Co FCF Yield % Related Terms

PELL Bio-Med Technology Co FCF Yield % Historical Data

* Premium members only.

The historical data trend for PELL Bio-Med Technology Co's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PELL Bio-Med Technology Co FCF Yield % Chart

PELL Bio-Med Technology Co Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
FCF Yield %
0.00 0.00 0.00 -11.10 -2.51

PELL Bio-Med Technology Co Quarterly Data
Dec21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -18.50 -5.32 -4.09 -2.56 -3.06

TPE:6949 vs VRTX, REGN, ALNY: FCF Yield % Comparison

For the Biotechnology subindustry, PELL Bio-Med Technology Co's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PELL Bio-Med Technology Co FCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PELL Bio-Med Technology Co's FCF Yield % distribution charts can be found below:

* The bar in red indicates where PELL Bio-Med Technology Co's FCF Yield % falls into.


TPE:6949
13GF Score
PELL Bio-Med Technology Co Ltd TPE:6949
FCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PELL Bio-Med Technology Co FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

PELL Bio-Med Technology Co's FCF Yield % for the fiscal year that ended in Dec. 2025 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-508.893 / 20296.55
=-2.51%

PELL Bio-Med Technology Co's annualized FCF Yield % for the quarter that ended in Dec. 2025 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-155.085 * 4 / 20296.55
=-3.06%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Yield % →
What does a FCF Yield % of -0.91 mean?
PELL Bio-Med Technology Co (TPE:6949) has a FCF Yield % of -0.91 as of Jun. 30, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on PELL Bio-Med Technology Co and its competitors. According to the industry distribution chart, PELL Bio-Med Technology Co ranks #290 out of 1415 companies in the Biotechnology industry, placing it in the top 20.5%.
Is PELL Bio-Med Technology Co's FCF Yield % too high?
PELL Bio-Med Technology Co's current FCF Yield % is -0.91. Based on the distribution chart, PELL Bio-Med Technology Co ranks #290 out of 1415 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, PELL Bio-Med Technology Co has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does PELL Bio-Med Technology Co's FCF Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, PELL Bio-Med Technology Co ranks #290 out of 1415 companies for FCF Yield %. This places PELL Bio-Med Technology Co in the top 21% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Biotechnology company?
A good FCF Yield % depends on the Biotechnology industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on PELL Bio-Med Technology Co and its competitors. PELL Bio-Med Technology Co's current FCF Yield % is -0.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PELL Bio-Med Technology Co stock overvalued right now?
PELL Bio-Med Technology Co (TPE:6949) has a current FCF Yield % of -0.91. The current FCF Yield % is -0.91. PELL Bio-Med Technology Co's overall GF Score™ is 13/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For PELL Bio-Med Technology Co (TPE:6949), the current FCF Yield % is -0.91 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PELL Bio-Med Technology Co Business Description

Address No. 87, Xinhu 2nd Road, 4th Floor, Neihu District, Taipei, TWN
PELL Bio-Med Technology Co Ltd is a company engaged in the research and development and application of autologous T Cell Therapy (Adoptive T Cell Therapy), CAR-T (Chimeric Antigen Receptor T cell), and Gene-Modified Adipose-Derived Stem Cell (Gene-Modified Adipose-Derived Stem Cell). The company's segments includes Cell products, Consulting services, and Others.
13GF Score

Get the complete analysis for TPE:6949

FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$856.00
Price